The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo

Overview of attention for article published in Acta Diabetologica, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,104 followers.

How does the antidiabetic drug metformin blunt NETosis? Metformin blunts NETosis and reduces circulating NETosis biomarkers https://t.co/mgAOCa5NCy https://t.co/X6HUOnAZ2J @NMC_IND @NITIAayog @MIT @Yale @UniofOxford @Cambridge_Uni @iiscbangalore @NCBS_B

@philippefroguel @kamleshkhunti 1/2 The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo https://t.co/fAXhD0GDUO

#In #ActaDiabetol The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo. https://t.co/nm5jvJlRfQ